Exelixis (EXEL) Financials

$36.54 +0.80 (+2.24%)

Closing price 04:00 PM Eastern

Extended Trading

$36.09 -0.45 (-1.23%)

As of 07:59 PM Eastern

Annual Income Statements for Exelixis

This table shows Exelixis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-162	-70	154	690	321	112	231	182	208	521
Consolidated Net Income / (Loss)	-162	-70	154	690	321	112	231	182	208	521
Net Income / (Loss) Continuing Operations	-162	-70	154	690	321	112	231	182	208	521
Total Pre-Tax Income	-162	-70	159	452	398	131	294	234	258	682
Total Operating Income	-121	-28	166	439	369	110	287	201	171	605
Total Gross Profit	33	185	437	827	935	951	1,382	1,553	1,758	2,092
Total Revenue	37	191	452	854	968	988	1,435	1,611	1,830	2,169
Operating Revenue	37	191	452	854	968	988	1,435	1,611	1,830	2,169
Total Cost of Revenue	3.90	6.55	15	26	33	36	53	58	73	76
Operating Cost of Revenue	3.90	6.55	15	26	33	36	53	58	73	76
Total Operating Expenses	155	213	272	389	565	841	1,095	1,352	1,587	1,488
Selling, General & Admin Expense	57	116	159	206	228	293	402	460	543	492
Research & Development Expense	96	96	112	182	337	548	694	892	1,044	910
Impairment Charge	-	-	-	-	-	-	-	0.00	0.00	52
Restructuring Charge	1.04	0.91	-	-	-	-	-	0.00	0.00	34
Total Other Income / (Expense), net	-40	-42	-7.33	13	29	21	7.49	33	87	77
Interest & Investment Income	0.79	2.58	4.88	13	28	20	7.67	33	87	77
Other Income / (Expense), net	-0.38	-12	-3.54	0.40	0.68	0.91	-0.18	-0.20	0.09	-0.13
Income Tax Expense	0.06	0.00	4.35	-238	77	19	63	52	50	160
Basic Earnings per Share	($0.77)	($0.28)	$0.52	$2.32	$1.06	$0.36	$0.73	$0.57	$0.65	$1.80
Weighted Average Basic Shares Outstanding	209.23M	250.53M	293.59M	297.89M	302.58M	308.27M	314.88M	321.53M	318.15M	290.03M
Diluted Earnings per Share	($0.77)	($0.28)	$0.49	$2.21	$1.02	$0.35	$0.72	$0.56	$0.65	$1.76
Weighted Average Diluted Shares Outstanding	209.23M	250.53M	312.00M	312.80M	315.01M	318.00M	322.36M	324.56M	321.46M	296.13M
Weighted Average Basic & Diluted Shares Outstanding	209.23M	250.53M	296.60M	300.13M	305.39M	311.99M	319.45M	324.09M	303.19M	279.88M

This table shows Exelixis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	73	-30	40	81	1.04	86	37	226	118	140
Consolidated Net Income / (Loss)	73	-30	40	81	1.04	86	37	226	118	140
Net Income / (Loss) Continuing Operations	73	-30	40	81	1.04	86	37	226	118	140
Total Pre-Tax Income	92	-31	48	100	5.82	103	49	293	155	185
Total Operating Income	83	-48	29	78	-18	82	29	276	136	163
Total Gross Profit	396	408	394	452	453	458	404	620	522	547
Total Revenue	412	424	409	470	472	480	425	637	540	567
Operating Revenue	412	424	409	470	472	480	425	637	540	567
Total Cost of Revenue	15	16	14	18	19	22	21	18	17	20
Operating Cost of Revenue	15	16	14	18	19	22	21	18	17	20
Total Operating Expenses	314	456	366	374	471	376	375	344	386	384
Selling, General & Admin Expense	115	119	131	142	138	131	114	132	112	134
Research & Development Expense	199	337	234	233	333	245	228	211	223	249
Restructuring Charge	-	-	0.00	0.00	0.00	-	33	0.48	0.10	0.25
Total Other Income / (Expense), net	9.43	17	19	23	23	21	20	17	19	22
Interest & Investment Income	9.50	17	20	23	23	21	20	17	19	21
Other Income / (Expense), net	-0.07	-0.34	-0.05	-0.01	0.29	-0.14	-0.09	-0.29	-0.03	0.27
Income Tax Expense	19	-1.25	8.25	19	4.78	18	12	67	37	45
Basic Earnings per Share	$0.23	($0.09)	$0.12	$0.25	$0.00	$0.28	$0.12	$0.78	$0.41	$0.49
Weighted Average Basic Shares Outstanding	322.15M	321.53M	324.42M	324.21M	315.50M	318.15M	300.76M	289.22M	285.62M	290.03M
Diluted Earnings per Share	$0.23	($0.10)	$0.12	$0.25	$0.00	$0.28	$0.12	$0.77	$0.40	$0.47
Weighted Average Diluted Shares Outstanding	325.07M	324.56M	326.28M	327.31M	319.25M	321.46M	305.53M	293.97M	291.48M	296.13M
Weighted Average Basic & Diluted Shares Outstanding	322.56M	324.09M	325.64M	318.38M	310.97M	303.19M	291.29M	285.25M	285.58M	279.88M

This table details how cash moves in and out of Exelixis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	61	12	32	128	-48	53	343	-161	-240	-46
Net Cash From Operating Activities	-141	210	166	416	527	209	401	363	333	700
Net Cash From Continuing Operating Activities	-141	210	166	416	527	209	401	363	333	700
Net Income / (Loss) Continuing Operations	-162	-70	154	690	321	112	231	182	208	521
Consolidated Net Income / (Loss)	-162	-70	154	690	321	112	231	182	208	521
Depreciation Expense	1.41	1.00	1.19	4.92	8.35	9.14	14	21	26	29
Non-Cash Adjustments To Reconcile Net Income	28	48	17	45	60	113	149	233	247	223
Changes in Operating Assets and Liabilities, net	-26	223	-6.95	-324	138	-25	7.52	-73	-147	-73
Net Cash From Investing Activities	50	-215	37	-298	-587	-131	-43	-524	-27	-117
Net Cash From Continuing Investing Activities	50	-215	37	-298	-587	-131	-43	-524	-27	-117
Purchase of Property, Plant & Equipment	-0.45	-1.70	-21	-33	-13	-30	-54	-28	-40	-28
Acquisitions	-	-	-	-	-	0.00	-10	-111	-123	-38
Purchase of Investments	-150	-369	-319	-558	-1,183	-1,070	-1,357	-1,451	-902	-928
Sale and/or Maturity of Investments	199	156	377	293	608	969	1,379	1,065	1,038	877
Net Cash From Financing Activities	152	16	-170	9.69	13	-25	-15	0.59	-546	-629
Net Cash From Continuing Financing Activities	152	16	-170	9.69	13	-25	-15	0.59	-546	-629
Repurchase of Common Equity	-	-	-	-	-	-	0.00	0.00	-550	-652
Issuance of Common Equity	146	2.19	22	17	22	25	24	24	33	62
Other Financing Activities, net	10	14	-6.56	-7.57	-9.90	-50	-39	-23	-29	-39
Cash Income Taxes Paid	0.19	0.19	0.54	11	7.87	4.12	13	128	186	170

This table details how cash moves in and out of Exelixis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	39	-174	39	-78	-68	-134	-3.43	-61	60	-41
Net Cash From Operating Activities	110	74	84	121	117	11	69	120	271	240
Net Cash From Continuing Operating Activities	110	74	84	121	117	11	69	120	271	240
Net Income / (Loss) Continuing Operations	73	-30	40	81	1.04	86	37	226	118	140
Consolidated Net Income / (Loss)	73	-30	40	81	1.04	86	37	226	118	140
Depreciation Expense	5.66	5.95	6.86	6.04	6.30	6.53	6.38	7.33	7.45	7.64
Non-Cash Adjustments To Reconcile Net Income	46	132	56	29	135	27	55	32	88	48
Changes in Operating Assets and Liabilities, net	-15	-34	-19	5.04	-25	-109	-29	-146	58	45
Net Cash From Investing Activities	-69	-246	-50	-74	35	62	112	82	-217	-93
Net Cash From Continuing Investing Activities	-69	-246	-50	-74	35	62	112	82	-217	-93
Purchase of Property, Plant & Equipment	-5.04	-9.72	-12	-5.94	-9.37	-13	-9.69	-6.57	-8.20	-3.98
Acquisitions	-3.00	-103	-37	-1.50	-85	-	-8.50	-18	-1.00	-10
Purchase of Investments	-387	-371	-312	-329	-183	-79	-138	-109	-375	-305
Sale and/or Maturity of Investments	326	238	311	263	311	153	268	215	167	226
Net Cash From Financing Activities	-2.04	-2.00	4.59	-125	-220	-206	-184	-262	5.70	-188
Net Cash From Continuing Financing Activities	-2.04	-2.00	4.59	-125	-220	-206	-184	-262	5.70	-188
Repurchase of Common Equity	-	-	0.00	-124	-217	-209	-185	-264	-12	-190
Issuance of Common Equity	2.89	5.21	7.14	10	6.92	9.11	8.32	15	20	19
Other Financing Activities, net	-4.93	-7.21	-2.56	-11	-9.75	-5.99	-6.99	-13	-2.17	-16

This table presents Exelixis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	332	596	655	1,422	1,886	2,137	2,616	3,071	2,942	2,948
Total Current Assets	179	469	485	897	1,011	1,445	1,835	1,619	1,318	1,468
Cash & Equivalents	142	152	183	315	267	319	647	501	263	217
Short-Term Investments	25	268	205	379	586	887	820	807	732	894
Accounts Receivable	5.18	40	81	163	119	161	283	215	237	265
Inventories, net	2.62	3.34	6.66	9.84	13	21	27	33	17	22
Prepaid Expenses	3.81	5.42	8.75	31	27	57	58	62	68	68
Plant, Property, & Equipment, net	1.43	2.07	26	51	49	67	104	111	129	119
Total Noncurrent Assets	152	125	145	474	826	625	677	1,342	1,496	1,361
Long-Term Investments	86	60	69	158	536	331	371	757	729	637
Goodwill	64	64	64	64	64	64	64	64	64	64
Noncurrent Deferred & Refundable Income Taxes	-	-	0.00	244	172	157	112	231	361	420
Other Noncurrent Operating Assets	2.31	1.23	12	8.29	53	73	131	291	342	240
Total Liabilities & Shareholders' Equity	332	596	655	1,422	1,886	2,137	2,616	3,071	2,942	2,948
Total Liabilities	473	506	370	135	200	258	406	583	678	703
Total Current Liabilities	52	269	115	105	143	205	338	324	394	404
Accounts Payable	6.40	6.57	9.58	11	12	24	24	33	34	38
Accrued Expenses	42	30	45	47	75	65	164	85	99	98
Customer Deposits	-	3.42	7.57	15	19	21	34	50	60	62
Current Employee Benefit Liabilities	3.63	20	21	32	37	51	62	77	93	110
Other Current Liabilities	-	-	-	-	-	44	53	79	108	95
Total Noncurrent Liabilities	421	238	255	29	57	54	68	259	284	300
Other Noncurrent Operating Liabilities	2.96	0.54	17	13	50	50	59	259	284	300
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-141	89	285	1,287	1,686	1,879	2,211	2,488	2,264	2,244
Total Preferred & Common Equity	-141	89	285	1,287	1,686	1,879	2,211	2,488	2,264	2,244
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-141	89	285	1,287	1,686	1,879	2,211	2,488	2,264	2,244
Common Stock	1,772	2,073	2,114	2,169	2,242	2,322	2,428	2,537	2,441	2,344
Retained Earnings	-1,913	-1,983	-1,829	-880	-559	-448	-217	-34	-173	-99
Accumulated Other Comprehensive Income / (Loss)	-0.23	-0.42	-0.35	-0.70	3.07	4.48	-0.76	-15	-3.75	-1.35

This table presents Exelixis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	2,961	3,143	3,142	2,977	2,804	2,773	2,960
Total Current Assets	1,842	1,638	1,591	1,443	1,292	1,477	1,550
Cash & Equivalents	675	541	464	397	260	198	258
Short-Term Investments	872	773	802	707	704	804	931
Accounts Receivable	215	234	233	248	241	397	270
Inventories, net	27	30	29	25	21	21	21
Prepaid Expenses	53	61	62	67	67	58	70
Plant, Property, & Equipment, net	108	116	115	121	127	130	124
Total Noncurrent Assets	1,012	1,390	1,437	1,413	1,384	1,165	1,286
Long-Term Investments	552	807	839	812	630	432	523
Goodwill	64	64	64	64	64	64	64
Noncurrent Deferred & Refundable Income Taxes	116	230	231	231	362	362	359
Other Noncurrent Operating Assets	280	290	304	306	329	308	340
Total Liabilities & Shareholders' Equity	2,961	3,143	3,142	2,977	2,804	2,773	2,960
Total Liabilities	470	588	615	629	676	653	685
Total Current Liabilities	302	328	340	377	373	346	394
Accounts Payable	31	33	26	26	26	29	59
Accrued Expenses	160	172	193	215	94	84	86
Customer Deposits	44	66	52	54	76	58	62
Current Employee Benefit Liabilities	67	57	68	81	73	72	91
Other Current Liabilities	-	-	-	-	104	103	96
Total Noncurrent Liabilities	168	261	275	252	303	308	291
Other Noncurrent Operating Liabilities	162	254	268	252	303	308	291
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,491	2,555	2,528	2,348	2,128	2,120	2,275
Total Preferred & Common Equity	2,491	2,555	2,528	2,348	2,128	2,120	2,275
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,491	2,555	2,528	2,348	2,128	2,120	2,275
Common Stock	2,513	2,559	2,531	2,488	2,392	2,325	2,362
Retained Earnings	-4.05	5.80	11	-126	-259	-200	-90
Accumulated Other Comprehensive Income / (Loss)	-18	-9.29	-14	-14	-5.20	-5.15	3.96

This table displays calculated financial ratios and metrics derived from Exelixis' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	48.03%	415.05%	136.34%	88.70%	13.35%	2.04%	45.31%	12.27%	13.60%	18.49%
EBITDA Growth	47.12%	70.68%	639.70%	171.56%	-14.78%	-68.27%	149.86%	-25.97%	-11.46%	221.96%
EBIT Growth	44.66%	67.37%	508.59%	170.52%	-15.73%	-70.02%	158.16%	-29.74%	-15.06%	253.54%
NOPAT Growth	45.90%	76.84%	919.63%	315.14%	-55.53%	-68.44%	139.48%	-30.40%	-12.03%	235.37%
Net Income Growth	38.10%	56.58%	319.63%	347.44%	-53.48%	-65.18%	106.71%	-21.11%	13.98%	150.89%
EPS Growth	42.54%	63.64%	275.00%	351.02%	-53.85%	-65.69%	105.71%	-22.22%	16.07%	170.77%
Operating Cash Flow Growth	40.08%	249.17%	-21.29%	151.02%	26.76%	-60.34%	91.79%	-9.53%	-8.08%	110.00%
Free Cash Flow Firm Growth	31.12%	287.54%	-35.46%	-53.39%	606.99%	-88.65%	292.72%	-45.57%	-79.98%	2,289.38%
Invested Capital Growth	3,917.47%	-944.27%	14.37%	353.12%	-31.79%	14.96%	8.95%	13.64%	27.57%	-8.20%
Revenue Q/Q Growth	7.47%	54.63%	10.36%	14.56%	1.22%	0.00%	0.00%	-1.66%	3.14%	4.18%
EBITDA Q/Q Growth	13.98%	63.47%	9.40%	20.58%	-8.27%	-30.42%	43.84%	-42.02%	197.80%	15.07%
EBIT Q/Q Growth	10.00%	58.22%	9.64%	20.29%	-8.49%	-32.19%	47.26%	-45.05%	317.92%	15.66%
NOPAT Q/Q Growth	10.74%	71.48%	-1.08%	86.76%	-48.25%	-28.85%	44.08%	-46.61%	349.20%	13.54%
Net Income Q/Q Growth	7.46%	50.90%	2.23%	87.28%	-47.58%	-26.53%	40.65%	-40.74%	125.65%	11.64%
EPS Q/Q Growth	10.47%	54.10%	-9.26%	87.29%	-47.69%	-27.08%	41.18%	-41.67%	140.74%	12.10%
Operating Cash Flow Q/Q Growth	9.66%	132.76%	-16.09%	14.06%	11.28%	-37.38%	18.71%	-5.91%	-15.92%	48.84%
Free Cash Flow Firm Q/Q Growth	3.66%	87.72%	-30.27%	554.58%	13.06%	-72.68%	69.40%	-57.35%	330.82%	82.94%
Invested Capital Q/Q Growth	10.30%	-28.29%	6.20%	163.16%	-16.31%	11.68%	7.17%	7.78%	24.82%	-11.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	89.52%	96.58%	96.67%	96.91%	96.58%	96.33%	96.32%	96.41%	96.04%	96.49%
EBITDA Margin	-278.05%	-15.83%	36.15%	52.02%	39.11%	12.16%	20.91%	13.79%	10.75%	29.20%
Operating Margin	-326.65%	-14.69%	36.67%	51.40%	38.18%	11.14%	19.98%	12.51%	9.34%	27.88%
EBIT Margin	-327.67%	-20.76%	35.89%	51.45%	38.25%	11.24%	19.96%	12.49%	9.34%	27.87%
Profit (Net Income) Margin	-435.12%	-36.68%	34.09%	80.82%	33.17%	11.32%	16.10%	11.31%	11.35%	24.04%
Tax Burden Percent	100.03%	100.00%	97.26%	152.64%	80.63%	85.44%	78.55%	77.78%	80.68%	76.47%
Interest Burden Percent	132.75%	176.70%	97.66%	102.92%	107.55%	117.90%	102.68%	116.43%	150.62%	112.76%
Effective Tax Rate	0.00%	0.00%	2.74%	-52.64%	19.37%	14.56%	21.45%	22.22%	19.32%	23.53%
Return on Invested Capital (ROIC)	-732.81%	0.00%	0.00%	508.06%	81.26%	29.42%	63.05%	39.39%	28.63%	89.30%
ROIC Less NNEP Spread (ROIC-NNEP)	-787.86%	0.00%	0.00%	504.97%	79.20%	28.21%	62.70%	38.08%	24.94%	85.91%
Return on Net Nonoperating Assets (RNNOA)	859.35%	0.00%	0.00%	-420.29%	-59.67%	-23.15%	-51.75%	-31.63%	-19.89%	-66.17%
Return on Equity (ROE)	126.54%	272.77%	82.41%	87.77%	21.59%	6.27%	11.30%	7.76%	8.74%	23.13%
Cash Return on Invested Capital (CROIC)	-459.43%	0.00%	0.00%	14.16%	119.06%	15.50%	54.48%	26.62%	4.40%	97.85%
Operating Return on Assets (OROA)	-37.16%	-8.56%	25.96%	42.29%	22.38%	5.52%	12.05%	7.08%	5.69%	20.53%
Return on Assets (ROA)	-49.34%	-15.13%	24.66%	66.43%	19.41%	5.56%	9.72%	6.41%	6.91%	17.70%
Return on Common Equity (ROCE)	126.54%	272.77%	82.41%	87.77%	21.59%	6.27%	11.30%	7.76%	8.74%	23.13%
Return on Equity Simple (ROE_SIMPLE)	114.87%	-78.62%	54.12%	53.60%	19.04%	5.95%	10.45%	7.33%	9.18%	23.23%
Net Operating Profit after Tax (NOPAT)	-85	-20	161	670	298	94	225	157	138	462
NOPAT Margin	-228.65%	-10.28%	35.66%	78.45%	30.78%	9.52%	15.69%	9.73%	7.53%	21.32%
Net Nonoperating Expense Percent (NNEP)	55.05%	-80.34%	-1.91%	3.09%	2.06%	1.21%	0.35%	1.31%	3.69%	3.39%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	6.30%	6.09%	20.60%
Cost of Revenue to Revenue	10.48%	3.42%	3.33%	3.09%	3.42%	3.67%	3.68%	3.59%	3.96%	3.51%
SG&A Expenses to Revenue	154.16%	60.66%	35.21%	24.17%	23.58%	29.71%	27.99%	28.54%	29.65%	22.69%
R&D to Revenue	259.20%	50.13%	24.79%	21.35%	34.82%	55.48%	48.34%	55.36%	57.05%	41.98%
Operating Expenses to Revenue	416.17%	111.27%	60.00%	45.52%	58.40%	85.18%	76.34%	83.90%	86.70%	68.61%
Earnings before Interest and Taxes (EBIT)	-122	-40	162	439	370	111	286	201	171	604
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-103	-30	164	444	378	120	300	222	197	633
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	47.82	31.56	4.51	3.07	3.31	2.62	2.08	3.30	4.32
Price to Tangible Book Value (P/TBV)	0.00	166.62	40.65	4.75	3.19	3.43	2.69	2.13	3.39	4.45
Price to Revenue (P/Rev)	34.47	22.31	19.88	6.81	5.34	6.31	4.03	3.21	4.08	4.47
Price to Earnings (P/E)	0.00	0.00	58.32	8.42	16.10	55.70	25.03	28.38	35.91	18.61
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	1.71%	11.87%	6.21%	1.80%	4.00%	3.52%	2.79%	5.37%
Enterprise Value to Invested Capital (EV/IC)	60.71	0.00	0.00	11.38	12.71	13.72	10.59	7.35	10.62	16.05
Enterprise Value to Revenue (EV/Rev)	38.90	20.79	18.87	5.81	3.91	4.75	2.75	1.93	3.13	3.67
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	52.19	11.17	9.99	39.04	13.15	13.99	29.16	12.56
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	52.58	11.29	10.21	42.26	13.77	15.44	33.55	13.16
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	52.91	7.41	12.69	49.87	17.52	19.84	41.61	17.20
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	18.92	51.55	11.93	7.17	22.44	9.84	8.57	17.21	11.36
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	19.39	64.45	80.35	8.66	94.65	20.28	29.35	270.54	15.70
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.97	2.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	-2.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.09	2.44	-2.00	-0.83	-0.75	-0.82	-0.83	-0.83	-0.80	-0.77
Leverage Ratio	-2.56	-18.03	3.34	1.32	1.11	1.13	1.16	1.21	1.27	1.31
Compound Leverage Factor	-3.40	-31.85	3.26	1.36	1.20	1.33	1.19	1.41	1.91	1.47
Debt to Total Capital	150.81%	67.92%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	67.92%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	150.81%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-50.81%	32.08%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	-4.04	-6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-1.59	9.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	-4.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-4.92	-9.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-1.94	14.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	-4.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-7.07	0.90	12.85	27.28	16.83	15.50	10.04	6.56	7.71	10.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.42	1.74	4.21	8.50	7.08	7.06	5.43	4.99	3.34	3.63
Quick Ratio	3.30	1.71	4.07	8.12	6.80	6.68	5.18	4.70	3.13	3.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-109	205	132	62	436	50	195	106	21	507
Operating Cash Flow to CapEx	0.00%	13,101.12%	789.41%	1,260.18%	4,105.94%	688.69%	739.15%	1,308.79%	823.65%	2,461.65%
Free Cash Flow to Firm to Interest Expense	-2.69	6.21	15.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-3.47	6.36	19.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-3.45	6.32	16.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.41	0.72	0.82	0.59	0.49	0.60	0.57	0.61	0.74
Accounts Receivable Turnover	7.39	8.39	7.44	7.00	6.87	7.06	6.47	6.48	8.09	8.63
Inventory Turnover	1.56	2.20	3.01	3.19	2.91	2.14	2.18	1.91	2.87	3.84
Fixed Asset Turnover	19.23	109.25	32.54	22.28	19.40	16.99	16.74	15.01	15.29	17.48
Accounts Payable Turnover	0.61	1.01	1.87	2.57	2.94	2.06	2.21	2.03	2.18	2.12
Days Sales Outstanding (DSO)	49.42	43.49	49.06	52.15	53.15	51.74	56.41	56.35	45.09	42.32
Days Inventory Outstanding (DIO)	234.13	165.84	121.07	114.25	125.30	170.36	167.29	191.59	127.35	95.09
Days Payable Outstanding (DPO)	600.40	361.16	195.51	141.83	123.97	177.17	165.30	179.40	167.12	172.31
Cash Conversion Cycle (CCC)	-316.85	-151.82	-25.38	24.57	54.48	44.92	58.40	68.54	5.31	-34.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	24	-201	-172	436	297	342	372	423	540	496
Invested Capital Turnover	3.20	-2.16	-2.42	6.48	2.64	3.09	4.02	4.05	3.80	4.19
Increase / (Decrease) in Invested Capital	24	-225	29	608	-139	44	31	51	117	-44
Enterprise Value (EV)	1,446	3,981	8,537	4,961	3,780	4,689	3,946	3,109	5,736	7,953
Market Capitalization	1,282	4,271	8,994	5,812	5,168	6,227	5,784	5,174	7,460	9,701
Book Value per Share	($0.62)	$0.31	$0.96	$4.31	$5.55	$6.06	$6.99	$7.71	$7.28	$7.86
Tangible Book Value per Share	($0.90)	$0.09	$0.75	$4.09	$5.34	$5.85	$6.79	$7.52	$7.08	$7.64
Total Capital	277	278	285	1,287	1,686	1,879	2,211	2,488	2,264	2,244
Total Debt	418	189	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	418	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	165	-290	-457	-852	-1,389	-1,537	-1,838	-2,065	-1,724	-1,749
Capital Expenditures (CapEx)	-0.90	1.61	21	33	13	30	54	28	40	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-41	-30	-19	98	16	34	30	-14	-72	-47
Debt-free Net Working Capital (DFNWC)	126	389	370	792	868	1,241	1,497	1,294	924	1,064
Net Working Capital (NWC)	126	200	370	792	868	1,241	1,497	1,294	924	1,064
Net Nonoperating Expense (NNE)	77	51	7.13	-20	-23	-18	-5.88	-26	-70	-59
Net Nonoperating Obligations (NNO)	165	-290	-457	-852	-1,389	-1,537	-1,838	-2,065	-1,724	-1,749
Total Depreciation and Amortization (D&A)	18	9.43	1.19	4.92	8.35	9.14	14	21	26	29
Debt-free, Cash-free Net Working Capital to Revenue	-109.35%	-15.91%	-4.10%	11.50%	1.67%	3.46%	2.10%	-0.87%	-3.91%	-2.19%
Debt-free Net Working Capital to Revenue	340.08%	203.36%	81.71%	92.71%	89.74%	125.64%	104.33%	80.34%	50.47%	49.05%
Net Working Capital to Revenue	340.08%	104.58%	81.71%	92.71%	89.74%	125.64%	104.33%	80.34%	50.47%	49.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.81)	($0.28)	$0.52	$2.32	$1.06	$0.36	$0.73	$0.57	$0.65	$1.80
Adjusted Weighted Average Basic Shares Outstanding	228.19M	290.87M	293.59M	297.89M	302.58M	308.27M	314.88M	321.53M	318.15M	290.03M
Adjusted Diluted Earnings per Share	($0.81)	($0.28)	$0.49	$2.21	$1.02	$0.35	$0.72	$0.56	$0.65	$1.76
Adjusted Weighted Average Diluted Shares Outstanding	228.19M	290.87M	312.00M	312.80M	315.01M	318.00M	322.36M	324.56M	321.46M	296.13M
Adjusted Basic & Diluted Earnings per Share	($0.81)	($0.28)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	209.23M	250.53M	296.31M	300.13M	305.39M	311.99M	319.45M	324.09M	303.19M	279.88M
Normalized Net Operating Profit after Tax (NOPAT)	-84	-19	161	307	298	94	225	157	138	528
Normalized NOPAT Margin	-226.69%	-9.95%	35.66%	35.98%	30.78%	9.52%	15.69%	9.73%	7.53%	24.33%
Pre Tax Income Margin	-434.98%	-36.68%	35.05%	52.95%	41.14%	13.25%	20.50%	14.55%	14.07%	31.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.99	-1.20	18.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-2.09	-0.60	18.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-2.97	-1.25	16.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-2.07	-0.64	16.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	264.90%	125.09%

This table displays calculated financial ratios and metrics derived from Exelixis' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	25.37%	-6.03%	14.83%	12.02%	14.62%	13.15%	4.02%	35.61%	14.33%	18.16%
EBITDA Growth	56.38%	-135.84%	-59.46%	-5.24%	-112.47%	307.63%	0.34%	237.27%	1,404.78%	94.06%
EBIT Growth	59.96%	-141.53%	-65.50%	-7.05%	-120.95%	268.65%	2.07%	254.02%	886.67%	100.22%
NOPAT Growth	77.46%	-135.78%	-64.31%	-5.81%	-104.79%	301.70%	-6.64%	238.36%	3,397.21%	81.99%
Net Income Growth	91.63%	-131.71%	-41.63%	14.87%	-98.58%	383.43%	-6.77%	178.54%	11,232.66%	63.55%
EPS Growth	91.67%	-133.33%	-42.86%	13.64%	-100.00%	380.00%	0.00%	208.00%	0.00%	67.86%
Operating Cash Flow Growth	32.13%	-23.60%	-42.86%	288.62%	6.63%	-85.66%	-18.47%	-1.18%	131.19%	2,172.85%
Free Cash Flow Firm Growth	566.80%	-233.10%	-163.87%	30.29%	-309.53%	42.24%	16.23%	-251.80%	38.29%	443.95%
Invested Capital Growth	13.00%	13.64%	36.49%	7.66%	10.16%	27.57%	22.92%	62.23%	30.12%	-8.20%
Revenue Q/Q Growth	-1.83%	2.96%	-3.57%	14.94%	0.44%	1.64%	-11.35%	49.84%	-15.32%	5.04%
EBITDA Q/Q Growth	-0.36%	-148.15%	183.90%	135.43%	-113.11%	901.75%	-59.46%	691.35%	-49.28%	19.25%
EBIT Q/Q Growth	-1.44%	-158.65%	159.44%	170.52%	-122.22%	572.13%	-64.03%	838.23%	-50.63%	20.16%
NOPAT Q/Q Growth	-1.69%	-151.22%	171.03%	163.37%	-105.00%	2,257.62%	-67.12%	854.53%	-51.30%	19.09%
Net Income Q/Q Growth	3.59%	-141.21%	232.66%	102.80%	-98.72%	8,114.99%	-56.36%	505.93%	-47.83%	18.55%
EPS Q/Q Growth	4.55%	-143.48%	220.00%	108.33%	-100.00%	0.00%	-57.14%	541.67%	-48.05%	17.50%
Operating Cash Flow Q/Q Growth	253.59%	-33.05%	14.54%	43.33%	-2.98%	-90.99%	551.05%	73.71%	126.97%	-11.45%
Free Cash Flow Firm Q/Q Growth	-18.63%	-511.30%	-9.52%	135.55%	-230.86%	-13.39%	-58.84%	35.59%	46.80%	731.96%
Invested Capital Q/Q Growth	0.06%	7.78%	2.87%	-2.96%	2.38%	24.82%	-0.87%	28.07%	-17.89%	-11.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	96.28%	96.24%	96.50%	96.23%	96.02%	95.46%	95.00%	97.23%	96.79%	96.48%
EBITDA Margin	21.42%	-10.02%	8.72%	17.85%	-2.33%	18.38%	8.41%	44.40%	26.60%	30.19%
Operating Margin	20.06%	-11.34%	7.05%	16.57%	-3.73%	17.05%	6.93%	43.30%	25.22%	28.80%
EBIT Margin	20.05%	-11.42%	7.04%	16.57%	-3.66%	17.02%	6.91%	43.25%	25.22%	28.84%
Profit (Net Income) Margin	17.78%	-7.12%	9.79%	17.28%	0.22%	17.83%	8.78%	35.49%	21.87%	24.68%
Tax Burden Percent	79.54%	96.01%	82.91%	80.87%	17.89%	83.00%	75.74%	77.21%	76.23%	75.69%
Interest Burden Percent	111.51%	64.91%	167.77%	128.96%	-33.64%	126.19%	167.73%	106.26%	113.75%	113.03%
Effective Tax Rate	20.46%	0.00%	17.09%	19.13%	82.11%	17.00%	24.26%	22.79%	23.77%	24.31%
Return on Invested Capital (ROIC)	70.65%	-32.15%	25.79%	56.37%	-2.87%	53.79%	19.97%	121.54%	80.41%	91.30%
ROIC Less NNEP Spread (ROIC-NNEP)	70.26%	-32.33%	25.01%	55.48%	-3.08%	52.86%	19.16%	120.80%	79.63%	90.36%
Return on Net Nonoperating Assets (RNNOA)	-58.96%	26.85%	-21.12%	-46.29%	2.55%	-42.14%	-15.19%	-92.00%	-62.48%	-69.60%
Return on Equity (ROE)	11.68%	-5.30%	4.68%	10.08%	-0.32%	11.64%	4.78%	29.54%	17.93%	21.70%
Cash Return on Invested Capital (CROIC)	67.10%	26.62%	-0.49%	19.82%	-2.23%	4.40%	7.47%	4.31%	55.64%	97.85%
Operating Return on Assets (OROA)	12.14%	-6.47%	4.04%	9.43%	-2.19%	10.36%	4.29%	29.45%	17.68%	21.24%
Return on Assets (ROA)	10.77%	-4.03%	5.62%	9.83%	0.13%	10.85%	5.45%	24.16%	15.33%	18.17%
Return on Common Equity (ROCE)	11.68%	-5.30%	4.68%	10.08%	-0.32%	11.64%	4.78%	29.54%	17.93%	21.70%
Return on Equity Simple (ROE_SIMPLE)	12.35%	0.00%	6.02%	6.50%	3.92%	0.00%	9.64%	16.51%	20.52%	0.00%
Net Operating Profit after Tax (NOPAT)	66	-34	24	63	-3.15	68	22	213	104	124
NOPAT Margin	15.96%	-7.94%	5.85%	13.40%	-0.67%	14.15%	5.25%	33.43%	19.23%	21.80%
Net Nonoperating Expense Percent (NNEP)	0.39%	0.18%	0.79%	0.89%	0.21%	0.93%	0.81%	0.74%	0.79%	0.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-1.35%	-	-	-	3.00%	-	-	-	5.50%
Cost of Revenue to Revenue	3.72%	3.76%	3.50%	3.77%	3.98%	4.54%	5.00%	2.77%	3.21%	3.52%
SG&A Expenses to Revenue	27.93%	28.13%	32.14%	30.16%	29.27%	27.40%	26.81%	20.72%	20.72%	23.70%
R&D to Revenue	48.29%	79.46%	57.30%	49.50%	70.47%	51.01%	53.55%	33.14%	41.25%	43.93%
Operating Expenses to Revenue	76.22%	107.59%	89.45%	79.66%	99.75%	78.41%	88.07%	53.93%	71.57%	67.68%
Earnings before Interest and Taxes (EBIT)	83	-48	29	78	-17	82	29	276	136	163
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	88	-42	36	84	-11	88	36	283	144	171
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.03	2.08	2.46	2.46	2.96	3.30	3.47	3.09	3.25	4.32
Price to Tangible Book Value (P/TBV)	2.08	2.13	2.52	2.53	3.05	3.39	3.57	3.18	3.35	4.45
Price to Revenue (P/Rev)	3.08	3.21	3.78	3.63	3.92	4.08	4.00	3.25	3.56	4.47
Price to Earnings (P/E)	16.40	28.38	40.92	37.89	75.55	35.91	35.99	18.70	15.86	18.61
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.10%	3.52%	2.44%	2.64%	1.32%	2.79%	2.78%	5.35%	6.31%	5.37%
Enterprise Value to Invested Capital (EV/IC)	7.51	7.35	9.58	9.75	11.66	10.62	10.81	7.46	10.11	16.05
Enterprise Value to Revenue (EV/Rev)	1.80	1.93	2.51	2.40	2.84	3.13	3.13	2.54	2.73	3.67
Enterprise Value to EBITDA (EV/EBITDA)	7.69	13.99	24.55	24.92	76.33	29.16	29.40	12.91	10.34	12.56
Enterprise Value to EBIT (EV/EBIT)	8.05	15.44	28.44	29.25	123.23	33.55	33.73	13.84	10.89	13.16
Enterprise Value to NOPAT (EV/NOPAT)	10.04	19.84	36.41	37.15	164.26	41.61	42.53	17.82	13.98	17.20
Enterprise Value to Operating Cash Flow (EV/OCF)	7.65	8.57	13.94	10.58	12.72	17.21	18.21	16.16	12.10	11.36
Enterprise Value to Free Cash Flow (EV/FCFF)	11.87	29.35	0.00	50.99	0.00	270.54	159.64	214.08	20.56	15.70
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.84	-0.83	-0.84	-0.83	-0.83	-0.80	-0.79	-0.76	-0.78	-0.77
Leverage Ratio	1.17	1.21	1.20	1.22	1.23	1.27	1.27	1.27	1.28	1.31
Compound Leverage Factor	1.31	0.79	2.01	1.58	-0.41	1.60	2.13	1.35	1.46	1.48
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	7.71	6.29	7.48	7.19	7.58	7.61	7.51	7.45	7.77	9.58
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.10	4.99	5.00	4.68	3.83	3.34	3.46	4.27	3.93	3.63
Quick Ratio	5.84	4.70	4.72	4.42	3.59	3.13	3.23	4.05	3.70	3.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	21	-84	-92	33	-43	-49	-77	-50	-27	168
Operating Cash Flow to CapEx	2,182.65%	758.40%	702.00%	2,037.70%	1,252.18%	80.48%	710.16%	1,819.60%	3,310.21%	6,041.31%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.57	0.57	0.57	0.60	0.61	0.62	0.68	0.70	0.74
Accounts Receivable Turnover	8.31	6.48	7.84	7.32	7.66	8.09	7.78	6.40	8.04	8.63
Inventory Turnover	2.00	1.91	2.02	2.05	2.58	2.87	3.12	3.23	3.39	3.84
Fixed Asset Turnover	15.77	15.01	14.96	15.34	15.50	15.29	15.17	16.43	16.96	17.48
Accounts Payable Turnover	2.00	2.03	2.37	2.75	2.34	2.18	2.71	2.91	1.82	2.12
Days Sales Outstanding (DSO)	43.95	56.35	46.56	49.85	47.63	45.09	46.89	57.03	45.40	42.32
Days Inventory Outstanding (DIO)	182.65	191.59	180.50	177.91	141.40	127.35	117.13	113.13	107.60	95.09
Days Payable Outstanding (DPO)	182.43	179.40	154.32	132.66	155.99	167.12	134.75	125.58	200.64	172.31
Cash Conversion Cycle (CCC)	44.16	68.54	72.75	95.10	33.04	5.31	29.27	44.58	-47.64	-34.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	393	423	435	423	433	540	535	685	563	496
Invested Capital Turnover	4.43	4.05	4.41	4.21	4.30	3.80	3.81	3.64	4.18	4.19
Increase / (Decrease) in Invested Capital	45	51	116	30	40	117	100	263	130	-44
Enterprise Value (EV)	2,948	3,109	4,171	4,117	5,042	5,736	5,787	5,111	5,693	7,953
Market Capitalization	5,046	5,174	6,291	6,223	6,957	7,460	7,379	6,545	7,405	9,701
Book Value per Share	$7.74	$7.71	$7.88	$7.76	$7.37	$7.28	$7.08	$7.28	$7.98	$7.86
Tangible Book Value per Share	$7.54	$7.52	$7.69	$7.57	$7.17	$7.08	$6.86	$7.06	$7.75	$7.64
Total Capital	2,491	2,488	2,555	2,528	2,348	2,264	2,128	2,120	2,275	2,244
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-2,099	-2,065	-2,120	-2,105	-1,915	-1,724	-1,593	-1,434	-1,713	-1,749
Capital Expenditures (CapEx)	5.04	9.72	12	5.94	9.37	13	9.69	6.57	8.20	3.98
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-7.10	-14	-3.11	-16	-37	-72	-44	130	-34	-47
Debt-free Net Working Capital (DFNWC)	1,540	1,294	1,310	1,251	1,067	924	919	1,132	1,155	1,064
Net Working Capital (NWC)	1,540	1,294	1,310	1,251	1,067	924	919	1,132	1,155	1,064
Net Nonoperating Expense (NNE)	-7.50	-3.48	-16	-18	-4.19	-18	-15	-13	-14	-16
Net Nonoperating Obligations (NNO)	-2,099	-2,065	-2,120	-2,105	-1,915	-1,724	-1,593	-1,434	-1,713	-1,749
Total Depreciation and Amortization (D&A)	5.66	5.95	6.86	6.04	6.30	6.53	6.38	7.33	7.45	7.64
Debt-free, Cash-free Net Working Capital to Revenue	-0.43%	-0.87%	-0.19%	-0.93%	-2.08%	-3.91%	-2.37%	6.44%	-1.62%	-2.19%
Debt-free Net Working Capital to Revenue	93.99%	80.34%	78.73%	72.97%	60.11%	50.47%	49.79%	56.19%	55.50%	49.05%
Net Working Capital to Revenue	93.99%	80.34%	78.73%	72.97%	60.11%	50.47%	49.79%	56.19%	55.50%	49.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.23	($0.09)	$0.12	$0.25	$0.00	$0.28	$0.12	$0.78	$0.41	$0.49
Adjusted Weighted Average Basic Shares Outstanding	322.15M	321.53M	324.42M	324.21M	315.50M	318.15M	300.76M	289.22M	285.62M	290.03M
Adjusted Diluted Earnings per Share	$0.23	($0.10)	$0.12	$0.25	$0.00	$0.28	$0.12	$0.77	$0.40	$0.47
Adjusted Weighted Average Diluted Shares Outstanding	325.07M	324.56M	326.28M	327.31M	319.25M	321.46M	305.53M	293.97M	291.48M	296.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	322.56M	324.09M	325.64M	318.38M	310.97M	303.19M	291.29M	285.25M	285.58M	279.88M
Normalized Net Operating Profit after Tax (NOPAT)	66	-34	24	63	-12	68	47	213	143	124
Normalized NOPAT Margin	15.96%	-7.94%	5.85%	13.40%	-2.61%	14.15%	11.10%	33.49%	26.54%	21.83%
Pre Tax Income Margin	22.35%	-7.41%	11.81%	21.37%	1.23%	21.48%	11.59%	45.96%	28.68%	32.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	75.64%	370.44%	264.90%	358.81%	250.24%	143.69%	125.09%

Frequently Asked Questions About Exelixis' Financials

When does Exelixis's fiscal year end?

According to the most recent income statement we have on file, Exelixis' financial year ends in January. Their financial year 2025 ended on January 3, 2025.

How has Exelixis' net income changed over the last 9 years?

Exelixis' net income appears to be on an upward trend, with a most recent value of $521.27 million in 2024, falling from -$161.74 million in 2015. The previous period was $207.77 million in 2023.

What is Exelixis's operating income?

Exelixis's total operating income in 2024 was $604.62 million, based on the following breakdown:

Total Gross Profit: $2.09 billion
Total Operating Expenses: $1.49 billion

How has Exelixis revenue changed over the last 9 years?

Over the last 9 years, Exelixis' total revenue changed from $37.17 million in 2015 to $2.17 billion in 2024, a change of 5,734.2%.

How much debt does Exelixis have?

Exelixis' total liabilities were at $703.49 million at the end of 2024, a 3.7% increase from 2023, and a 48.7% increase since 2015.

How much cash does Exelixis have?

In the past 9 years, Exelixis' cash and equivalents has ranged from $141.63 million in 2015 to $647.17 million in 2021, and is currently $217.37 million as of their latest financial filing in 2024.

How has Exelixis' book value per share changed over the last 9 years?

Over the last 9 years, Exelixis' book value per share changed from -0.62 in 2015 to 7.86 in 2024, a change of -1,368.1%.

Remove Ads

Related Companies

This page (NASDAQ:EXEL) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exelixis (EXEL) Financials

Frequently Asked Questions About Exelixis' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exelixis (EXEL) Financials

Annual Income Statements for Exelixis

Quarterly Income Statements for Exelixis

Annual Cash Flow Statements for Exelixis

Quarterly Cash Flow Statements for Exelixis

Annual Balance Sheets for Exelixis

Quarterly Balance Sheets for Exelixis

Annual Metrics and Ratios for Exelixis

Quarterly Metrics and Ratios for Exelixis

Frequently Asked Questions About Exelixis' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools